Tags
BiotechNanomedicineCMCDevelopment
The client is a prolific academic research group with a novel proprietary nanomedicine approach for mRNA delivery.
- Supported the creation of a GMP-like structure, with a flexible quality management routine that ensures traceability, documentation control, and quality oversight while remaining adaptable to a research setting.
- Designed CMC activities to develop a robust, scalable, and reproducible manufacturing process.
- Our strategic support positioned the technology as a platform for multiple therapeutic verticals, properly de-risked for potential B2B licensing.
- Supported funding applications to PT2030 and Tecnimede Open Innovation Competition